SPONSORED CONTENT The upcoming rebate model pilot program is already reshaping how covered entities think about claims workflows. Many teams [...] …
Tag: Industry Insights
SPONSORED CONTENT HRSA has made several changes to the data request list (DRL) for fiscal year 2026 that covered entities [...] …
SPONSORED CONTENT Whether it’s new manufacturer restrictions affecting script and data qualification, amended state laws or regulations, or updated audit [...] …
SPONSORED CONTENT The 340B program has faced increased scrutiny and significant proposed changes in 2025. Our content for 340B Report [...] …
SPONSORED CONTENT As the healthcare landscape evolves under the weight of federal reforms, two major developments, the HRSA 340B Rebate Pilot and [...] …
SPONSORED CONTENT The term “specialty medication” is often associated with a hefty price tag and numerous challenges related to claims [...] …
SPONSORED CONTENT Covered entities do incredible work for their patients every day. The 340B program plays a critical role in [...] …
SPONSORED CONTENT The U.S. drug pricing infrastructure is entering a transformative era. On August 1, 2025, the Health Resources and [...] …
SPONSORED CONTENT Consider the following scenario: A recent change in electronic health record billing at one of your outpatient clinics [...] …
SPONSORED CONTENT The 340B program has been bombarded with threats over the past five years. 340B professionals have had their hands [...] …
